Hey there, time traveller!
This article was published 19/4/2013 (1168 days ago), so information in it may no longer be current.
The province has introduced 81 more generic drugs to the pharmacare program.
Health Minister Theresa Oswald said the lower drug prices will save Manitoba families $3.7 million a year.
"The addition of these drugs to the formulary will lower prescription drug costs and provide more choice and significant savings to families dealing with medical conditions such as diabetes, hypertension, depression and HIV," Oswald said.
The addition the 81 new drugs to pharmacare includes a new pediatric strength for Tamiflu, used to treat influenza; new strengths of the drug Prezista, used in the treatment of HIV; and new formulations of Saizen and Nutropin AQ NuSpin, used to help children who are growth -hormone deficient.
"With this enhancement to pharmacare, we've added 234 new drugs to the formulary since January," Oswald said.
Pharmacare is a universal prescription drug program for Manitobans, with benefits based on family income. It covers 100 per cent of eligible drug costs once the income-based deductible is reached regardless of medical condition or age.
More information about the Manitoba Pharmacare Program is available at: www.gov.mb.ca/health/pharmacare.